Subject(s)
COVID-19/epidemiology , Congresses as Topic/standards , Periodicals as Topic/standards , Practice Guidelines as Topic/standards , Societies, Medical/standards , Stroke/epidemiology , COVID-19/prevention & control , Congresses as Topic/organization & administration , Europe/epidemiology , Humans , Societies, Medical/organization & administration , Stroke/therapySubject(s)
European Union/organization & administration , Gastroenterology/statistics & numerical data , Societies, Medical/organization & administration , 2019-nCoV Vaccine mRNA-1273/pharmacology , Administration, Intravenous , Antibiotic Prophylaxis/methods , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/therapeutic use , Cholecystectomy/methods , Cholecystectomy/standards , Clinical Trials as Topic , Colitis, Ulcerative/drug therapy , Crohn Disease , Emergency Treatment , Endoscopy/methods , Gastroenterology/organization & administration , Gastroparesis/surgery , Heterocyclic Compounds, 3-Ring/therapeutic use , Humans , Inflammatory Bowel Diseases/drug therapy , Inflammatory Bowel Diseases/immunology , Janus Kinase Inhibitors/therapeutic use , Myotomy/methods , Preoperative Care , Remission Induction , Treatment Outcome , Tumor Necrosis Factor Inhibitors/adverse effects , Tumor Necrosis Factor Inhibitors/therapeutic use , User-Computer InterfaceSubject(s)
Neuroendocrinology , Publishing , History, 21st Century , Humans , International Cooperation , Internationality , Neuroendocrinology/history , Neuroendocrinology/trends , Publishing/history , Publishing/trends , Societies, Medical/history , Societies, Medical/organization & administration , Societies, Medical/trendsABSTRACT
Influenza and pneumococcal disease represent a well-known burden on healthcare systems worldwide, as well as they still have an attributed morbidity and mortality, especially in elderly individuals and vulnerable populations. In the context of the ongoing pandemic of COVID-19, a series of considerations in favor of extensive influenza and pneumococcal vaccination campaign are emerging, including a possible reduction of hospital extra burden and saving of sanitary resources. In addition, recent studies have suggested that prior vaccinations towards non SARS-CoV-2 pathogens might confer some protection against COVID-19. In this paper the authors consider all factors in support of these hypotheses and provide a consensus statement to encourage influenza and pneumococcal vaccinations in targeted populations.
Subject(s)
COVID-19 , Health Promotion , Influenza Vaccines , Influenza, Human/prevention & control , Pandemics , Pneumococcal Infections/prevention & control , Pneumococcal Vaccines , Pulmonary Medicine/organization & administration , Societies, Medical/organization & administration , Vaccination , Adolescent , Adult , Aged , Aged, 80 and over , COVID-19/prevention & control , Female , Health Services Needs and Demand , Humans , Italy , Male , Middle Aged , Pneumococcal Infections/microbiology , Streptococcus pneumoniae , Young AdultSubject(s)
Congresses as Topic/organization & administration , Radiology/organization & administration , Societies, Medical/organization & administration , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/virology , Congresses as Topic/statistics & numerical data , Decision Making/ethics , Economic Status/statistics & numerical data , Germany/epidemiology , Humans , Interviews as Topic , Knowledge , Male , Radiology/standards , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , User-Computer InterfaceSubject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Delivery of Health Care/organization & administration , Global Health , Health Services Accessibility/organization & administration , Ophthalmology/organization & administration , Pandemics , Pneumonia, Viral/epidemiology , COVID-19 , Global Burden of Disease , Humans , SARS-CoV-2 , Societies, Medical/organization & administration , United StatesSubject(s)
COVID-19/prevention & control , Endocrinology/standards , General Surgery/standards , Societies, Medical/standards , COVID-19/epidemiology , COVID-19/transmission , Communicable Disease Control/standards , Congresses as Topic/organization & administration , Congresses as Topic/standards , Endocrinology/organization & administration , General Surgery/organization & administration , Humans , Pandemics/prevention & control , Social Interaction , Societies, Medical/organization & administration , Telecommunications/standards , UncertaintySubject(s)
Congresses as Topic , Diabetes Mellitus/therapy , Endocrinology , Adolescent , Blood Glucose Self-Monitoring/methods , Blood Glucose Self-Monitoring/trends , COVID-19/blood , COVID-19/complications , COVID-19/epidemiology , COVID-19/therapy , Child , Child, Preschool , Congresses as Topic/history , Congresses as Topic/trends , Cross-Cultural Comparison , Cultural Diversity , Developing Countries , Diabetes Complications/blood , Diabetes Complications/epidemiology , Diabetes Complications/psychology , Diabetes Complications/therapy , Diabetes Mellitus/blood , Diabetes Mellitus/epidemiology , Diabetes Mellitus/psychology , Diet , Dyslipidemias/complications , Dyslipidemias/epidemiology , Dyslipidemias/therapy , Endocrinology/history , Endocrinology/methods , Endocrinology/organization & administration , Endocrinology/trends , Female , History, 21st Century , Humans , Male , Obesity/complications , Obesity/epidemiology , Obesity/therapy , Societies, Medical/history , Societies, Medical/organization & administration , Societies, Medical/standards , Societies, Medical/trends , Young AdultABSTRACT
Changes that COVID-19 induced in endocrine daily practice as well as the role of endocrine and metabolic comorbidities in COVID-19 outcomes were among the striking features of this last year. The aim of this statement is to illustrate the major characteristics of the response of European endocrinologists to the pandemic including the disclosure of the endocrine phenotype of COVID-19 with diabetes, obesity and hypovitaminosis D playing a key role in this clinical setting with its huge implication for the prevention and management of the disease. The role of the European Society of Endocrinology (ESE) as a reference point of the endocrine community during the pandemic will also be highlighted, including the refocusing of its educational and advocacy activities.
Subject(s)
COVID-19/epidemiology , COVID-19/therapy , Endocrinologists/organization & administration , Endocrinology/organization & administration , COVID-19/complications , COVID-19/prevention & control , Community Networks/organization & administration , Community Networks/trends , Delivery of Health Care/history , Delivery of Health Care/organization & administration , Delivery of Health Care/trends , Endocrine System Diseases/diagnosis , Endocrine System Diseases/epidemiology , Endocrine System Diseases/etiology , Endocrine System Diseases/therapy , Endocrinologists/history , Endocrinologists/trends , Endocrinology/history , Endocrinology/trends , Europe/epidemiology , History, 21st Century , Humans , Pandemics , Phenotype , Physician's Role , Practice Patterns, Physicians'/history , Practice Patterns, Physicians'/organization & administration , Practice Patterns, Physicians'/trends , Societies, Medical/history , Societies, Medical/organization & administration , Societies, Medical/trends , Telemedicine/history , Telemedicine/organization & administration , Telemedicine/trendsSubject(s)
COVID-19 , Leadership , Politics , Societies, Medical/organization & administration , Female , Human Rights , Humans , Male , TurkeyABSTRACT
The Japanese Respiratory Society (JRS) has recommended spirometry for the diagnosis of respiratory diseases. It is indispensable for the confirmation of airflow obstruction by spirometry in chronic obstructive pulmonary disease (COPD) diagnosis. However, the coronavirus disease 2019 (COVID-19) pandemic has made it difficult for many clinics to perform spirometry as it may lead to possible aerosol infections. Thus, the diagnosis of COPD, especially in the early stage, has become difficult. To overcome this situation, JRS issued a "Flowchart of Working Diagnosis and Management of COPD during the COVID-19 Pandemic". This flowchart may help physicians provisionally diagnose COPD patients without performing spirometry, offering them appropriate intervention even in epidemic and pandemic situations.